Madrigal Pharmaceuticals MDGL shares soared 10.9% on Wednesday. The uptrend was observed after the U.S. Patent and Trademark ...

Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...

Amgen's expanding rare disease and biosimilar portfolios, coupled with growth potential and dividend history make AMGN stock ...

World IP Review is set to host the highly anticipated AI and IP USA 2025, a one-day event on October 9, 2025 in New York. The ...

Merck is acquiring Verona Pharma for $10 billion, gaining COPD drug Ohtuvayre as part of its strategy to offset Keytruda's ...

The antibody treatment could compete with Sanofi’s Dupixent and Eli Lilly’s Ebgylss, while offering the potential for less ...

US pharma major AbbVie announced it plan to acquire Capstan Therapeutics, along with its autoimmune disease candidate ...

Opinion: Knobbe Marten's Ted Cannon analyzes the sharp rise in denials of patent validity challenges at the Patent Trial and Appeal Board and explains why filing a petition promptly can help a ...

NEW YORK-- (BUSINESS WIRE)-- Patlytics, the AI-powered patent workflow platform, today announced the appointment of Michelle K. Lee as Senior Strategic Advisor. A pioneering and respected leader ...

You successfully represented Regeneron Pharmaceuticals Inc. in Regeneron Pharmaceuticals Inc. v. Mylan Pharmaceuticals, Inc., in which the US District Court for the Northern District of West Virginia ...

Samsung secures interim patent licence in UK court ruling against ZTE, a key step in a multi-country FRAND dispute over mobile technologies.